Fig. 1
From: CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
Screening and validation of CD22 expression. A Heat maps for the expression of 13 target genes from RNA-seq data in 1 normal esophagus and 81 cases of ESCC in TCGA. B Expression of the 13 target genes in 2 ESCC patients. C Expression of the 13 target genes in two ESCC lines (KYSE140 and KYSE150). D Venn diagram of the bioinformatics analysis and qPCR results. E CD22 expression in KYSE140 and KYSE150 cells was examined by immunofluorescence. White arrows show CD22 expressed on the cell membrane. Scale bar: 100 μm